Page 2 - Aegis Sciences News Today

Despite a few less successful elements, the overall portfolio increased test availability and RADx is now becoming a model for federal investing.

On August 9, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a new way of administering

BIP Wealth, Cumberland Pharmaceuticals, FirstBank announce updates

Starting today, Aegis Sciences will begin testing for monkeypox using CDC's orthopoxvirus test, which detects most non-smallpox related orthopoxviruses, including monkeypox virus.

All five of the commercial labs named by HHS have begun monkeypox testing in the United States amid a growing outbreak.

Roundup: U.S. expands monkeypox testing, vaccine supply as cases exceed 1,000-

Does the monkeypox disease “constitutes a public health emergency of international concern,” that is what officials at the World Health Organization (WHO) are pondering as they announce a second meeting

Soaring case numbers are the result of a slow and inadequate response to the outbreak, experts say.

Local health departments are working with the CDC and the US Department of Health and Human Services to request tecovirimat through a complicated, 120-page protocol.

© Provided by Xinhua Over 132,000 doses of JYNNEOS, the vaccine licensed by the U.S. FDA indicated for prevention of smallpox and monkeypox, had been d